Fmoc-S-benzyl-L-cysteine is an Fmoc-protected, cysteine-derived amino acid derivative in which the cysteine thiol is converted to an S-benzyl thioether while the α-amino and α-carboxyl functionalities are present for peptide coupling. The molecule contains an Fmoc (fluorenylmethoxycarbonyl) carbamate on the amino group and a benzyl-protected sulfur substituent on the side chain, with stereochemistry indicated as L at the α-carbon. In peptide synthesis workflows, it functions as a protected cysteine building block that can be incorporated into peptide chains under chemoselective conditions while the thioether side-chain protection supports controlled handling of sulfur-containing residues and subsequent derivatization strategies.
Fmoc-S-benzyl-L-cysteine is an Fmoc-protected L-cysteine derivative in which the thiol side chain is masked as an S-benzyl thioether, while the amino group is protected as the fluorenylmethoxycarbonyl (Fmoc) carbamate. The molecule retains the stereogenic center of L-cysteine, providing predictable chirality for peptide coupling and downstream thio-functional transformations. The benzylic thioether and the aromatic Fmoc group introduce distinct hydrophobicity and photochemically stable protecting-group behavior, while the carboxylate is typically present as an activated form suitable for peptide assembly or can be converted into peptide-compatible derivatives. The sulfur substituent can be selectively unmasked under controlled conditions to regenerate a cysteine thiol for disulfide formation, thioether/thiol conjugation, or further side-chain functionalization, making it a practical chiral intermediate for peptide chemistry and sulfur-containing building block synthesis.
1. Peptide Synthesis
Fmoc-S-benzyl-L-cysteine is used in solid-phase peptide synthesis and solution-phase peptide assembly where cysteine residue incorporation is required with controlled side-chain sulfur chemistry. The Fmoc carbamate enables standard N-terminal deprotection strategies, while the S-benzyl thioether protects the sulfur from undesired oxidation during coupling cycles and handling. The retained L-configuration supports stereochemically consistent peptide backbones, and the sulfur-protecting group can be removed later to generate a reactive thiol for disulfide bond formation or selective conjugation. The resulting cysteine-bearing peptides and peptide fragments can be carried forward into structural studies, scaffold optimization, and synthesis of sulfur-functional analogs that depend on thiol availability at defined stages of assembly.
2. Side-Chain Functionalization
Fmoc-S-benzyl-L-cysteine serves as a chiral sulfur-containing intermediate for side-chain derivatization workflows that require delayed thiol exposure. The S-benzyl thioether provides a stable handle that can be converted to a free thiol under conditions compatible with sensitive peptide or protecting-group arrays, enabling formation of disulfides, thioacetals, thioethers, or thiol-reactive adducts. The Fmoc group supports orthogonal protection logic, allowing sequential deprotection and functional-group installation without premature sulfur reactivity. Downstream, sulfur-unmasked products can be used to generate redox-active peptide analogs, site-specific probes, and chemically defined conjugates used in biochemical research and applied molecular construction.
3. Bioconjugation Chemistry
Fmoc-S-benzyl-L-cysteine is applicable to bioconjugation and chemical biology workflows that require cysteine-selective coupling motifs with controlled chemoselectivity. The protected amino functionality supports peptide fragment generation or linker synthesis, while the masked thiol reduces background reactions during preparation of peptide-based targeting ligands or carrier conjugates. Thiol regeneration from the S-benzyl thioether can enable site-specific conjugation to maleimides, haloacetamides, activated disulfides, or other electrophiles that target cysteine residues. The stereodefined L-cysteine framework aids in producing consistent conjugate architectures for downstream labeling, affinity reagent construction, and mechanistic studies where sulfur chemistry governs binding-site accessibility.
4. Peptidomimetics And SAR Studies
Fmoc-S-benzyl-L-cysteine can be employed in peptidomimetic and structure-activity relationship studies where sulfur-containing side chains modulate conformational preferences and binding interactions. The compound's protected amine and carboxyl functionality support incorporation into constrained analogs, thioether-stabilized variants, or cysteine-mimicking scaffolds that preserve the stereochemical identity of the original amino acid. The S-benzyl thioether can be used as a protected sulfur precursor to tune redox properties or to introduce thioether substitutions that alter polarity and stability relative to free thiols. Synthesized thio-functional analog series can then be used as defined chemical probes for SAR mapping, fragment elaboration, and mechanistic comparisons across related peptide-like structures.
5. Pharmaceutical Manufacturing Intermediates
Fmoc-S-benzyl-L-cysteine is suitable for industrial peptide intermediate preparation where orthogonally protected amino acid building blocks are required for scalable manufacturing routes. The Fmoc protecting group supports controlled N-terminal deprotection logic during peptide assembly, while the S-benzyl thioether helps manage sulfur oxidation risk during bulk synthesis and purification steps. The L-stereocenter and sulfur-protection strategy enable reproducible incorporation of cysteine residues into API-relevant peptide sequences, including intermediates used for further conversion into disulfide-containing products or thiol-reactive derivatives. The compound's role as a protected amino acid derivative supports process chemistry planning for downstream transformations that depend on timed exposure of the cysteine thiol within a larger protected framework.
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More